PRESS RELEASE: San Diego, CA (August 22, 2011) – Eidogen-Sertanty, Inc. has announced a new oncology knowledgebase focusing on emerging and hot targets. Complementing its flagship Kinase Knowledgebase (KKB), Eidogen-Sertanty's Oncology Knowledgebase (OKB) focuses on a broad spectrum of targets relevant to Colon cancer, Esophageal cancer, Glioma, Head and Neck cancer, Kidney cancer, Leukemia, Liver cancer, Lung cancer, Lymphoma, Melanoma, Ovarian cancer, Prostate cancer, Skin cancer, and Stomach cancer.

The Kinase Knowledgebase (KKB) is an Eidogen-Sertanty's database of kinase structure-activity and chemical synthesis data (register to download a free sample dataset in IJC or SDF format). The KKB represents the first gene-family wide implementation of our proprietary web-based technology for the capture, curation, and display of biological activity and chemical synthesis data from scientific literature and patent. Kinase Knowledgebase (KKB™), a small molecule activity data is manually curated by a experienced team of PhD chemists and biologists from patents and peer-reviewed publications.